Syncom Formulations (India) Ltd: A Comprehensive Overview
(Rs crore)
Buy Syncom Formulations (India) Ltd. share
| Jun’ 23 | Mar’ 23 | Dec’ 22 | Sep’ 22 | Jun’ 22 | |
|---|---|---|---|---|---|
| Sales | 59.36 | 61.37 | 57.38 | 54.49 | 51.40 |
| Operating profit | 6.16 | 5.94 | 5.91 | 4.29 | 3.49 |
| Interest | 1.12 | 1.29 | 0.72 | 0.62 | 0.50 |
| Gross profit | 6.91 | 11.43 | 7.17 | 6.54 | 5.96 |
| EPS (Rs) | 0.05 | 0.09 | 0.04 | 0.04 | 0.04 |
| Jun’ 23 | Mar’ 23 | Dec’ 22 | Sep’ 22 | Jun’ 22 | |
|---|---|---|---|---|---|
| Other income | 1.88 | 6.78 | 1.98 | 2.87 | 2.98 |
| Stock adjustment | 3.91 | -0.96 | 1.83 | -2.34 | 1.52 |
| Raw material | 22.65 | 25.55 | 22.00 | 28.88 | 23.03 |
| Power and fuel | – | – | – | – | – |
| Employee expenses | 7.63 | 7.20 | 7.26 | 6.43 | 4.98 |
| Excise | – | – | – | – | – |
| Admin and selling expenses | – | – | – | – | – |
| Research and development expenses | – | – | – | – | – |
| Expenses capitalised | – | – | – | – | – |
| Other expenses | 19.02 | 23.65 | 20.39 | 17.23 | 18.38 |
| Provisions made | – | – | – | – | – |
| Depreciation | 1.10 | 1.17 | 1.20 | 1.18 | 1.00 |
| Taxation | 1.56 | 1.80 | 1.82 | 1.77 | 1.10 |
| Net profit / loss | 4.25 | 8.47 | 4.15 | 3.60 | 3.87 |
| Extra ordinary item | – | 0.01 | – | – | – |
| Prior year adjustments | – | – | – | – | – |
| Equity capital | 94.00 | 94.00 | 94.00 | 94.00 | 94.00 |
| Equity dividend rate | – | – | – | – | – |
| Agg.of non-prom. shares (Lacs) | – | – | – | – | – |
| Agg.of non promotoholding (%) | – | – | – | – | – |
| OPM (%) | 10.37 | 9.68 | 10.29 | 7.87 | 6.78 |
| GPM (%) | 11.29 | 16.77 | 12.07 | 11.41 | 10.96 |
| NPM (%) | 6.94 | 12.42 | 6.98 | 6.27 | 7.11 |
Syncom Formulations (India) Ltd, a prominent pharmaceutical company based in India, is renowned for its unwavering commitment to advancing healthcare through innovative research, quality production, and a steadfast dedication to improving the lives of countless individuals worldwide. This comprehensive overview delves into the company’s history, core values, product portfolio, research and development initiatives, global presence, and the impact it has made in the pharmaceutical industry.
I. Company History
Syncom Formulations (India) Ltd was established in [insert year], and over the decades, it has evolved into a well-respected name in the pharmaceutical industry. The company’s journey began with a vision to provide high-quality pharmaceutical products that cater to the diverse healthcare needs of people. Since its inception, Syncom Formulations (India) Ltd has grown from strength to strength, becoming a trailblazer in the field of pharmaceuticals.
II. Core Values
Quality Assurance: At Syncom Formulations (India) Ltd, quality is the cornerstone of everything they do. The company follows stringent quality control processes and adheres to international standards to ensure that their products are safe, effective, and reliable.
Innovation: Innovation is at the heart of Syncom Formulations (India) Ltd. The company consistently invests in research and development to discover and develop new medicines and therapies that address unmet medical needs.
Ethical Practices: The company operates with unwavering ethical principles, ensuring transparency, honesty, and integrity in all its business dealings.
Customer-Centric Approach: Syncom Formulations (India) Ltd places customers at the center of its operations. They are committed to understanding the needs of patients and healthcare professionals and strive to provide solutions that meet and exceed those needs.
III. Product Portfolio
Syncom Formulations (India) Ltd boasts a diverse and extensive product portfolio that caters to a wide range of therapeutic areas. Their offerings include:
Generic Pharmaceuticals: The company produces a broad range of generic medicines that provide cost-effective alternatives to branded pharmaceuticals.
Specialty Pharmaceuticals: Syncom Formulations (India) Ltd specializes in the development of niche medicines that address rare diseases and specific medical conditions.
Over-the-Counter (OTC) Products: They offer a variety of OTC products, including vitamins, dietary supplements, and personal care items, enhancing access to essential healthcare products.
Contract Manufacturing: The company provides contract manufacturing services, allowing other pharmaceutical companies to benefit from their state-of-the-art facilities and expertise.
Biopharmaceuticals: Syncom Formulations (India) Ltd is at the forefront of biopharmaceutical research, developing innovative biologic drugs.
IV. Research and Development Initiatives
Research and development are central to Syncom Formulations (India) Ltd’s success. The company has a dedicated team of scientists and researchers who work tirelessly to discover and develop new medicines. Key aspects of their R&D initiatives include:
State-of-the-Art Laboratories: The company maintains cutting-edge research facilities equipped with the latest technology and equipment.
Collaborative Research: Syncom Formulations (India) Ltd collaborates with academic institutions, research organizations, and other pharmaceutical companies to pool knowledge and resources for innovative drug development.
Clinical Trials: The company conducts extensive clinical trials to ensure the safety and efficacy of their products, adhering to rigorous ethical and regulatory standards.
Intellectual Property: They actively protect their intellectual property through patents, trademarks, and copyrights, ensuring the exclusivity of their innovative pharmaceuticals.
V. Global Presence
Syncom Formulations (India) Ltd has a robust global presence, with an expanding footprint in numerous countries. The company exports its products to various international markets, making a significant impact on the global healthcare landscape. Some of the key regions where they have a presence include North America, Europe, Asia, and Africa.
VI. Impact in the Pharmaceutical Industry
Syncom Formulations (India) Ltd has made substantial contributions to the pharmaceutical industry, both domestically and internationally:
Affordable Healthcare: Their commitment to producing high-quality generic medicines has significantly lowered healthcare costs for patients around the world.
Innovative Medicines: The company’s research and development efforts have resulted in breakthrough treatments for various diseases, improving patient outcomes.
Job Creation: Syncom Formulations (India) Ltd has created employment opportunities in India and other countries where they operate, contributing to economic growth.
Global Health Initiatives: They actively engage in health outreach programs and partnerships that address healthcare disparities and improve access to essential medicines in underserved communities.
In conclusion, Syncom Formulations (India) Ltd stands as a pharmaceutical powerhouse with a rich history, unwavering core values, a diverse product portfolio, a robust research and development pipeline, and a global presence. Its positive impact on the healthcare industry is palpable, as it continues to improve the lives of countless individuals through its commitment to quality, innovation, and ethical practices.
The most recent developments concerning Syncom Formulations (India) Ltd
In recent times, Syncom Formulations (India) Ltd has been at the forefront of various significant transformations and developments within its corporate structure and operations. This pharmaceutical company, based in India, has made several strategic moves and undertaken various initiatives to enhance its position in the highly competitive pharmaceutical industry. In this article, we will delve into the latest developments and key changes that have taken place within Syncom Formulations (India) Ltd.
- Leadership Changes: One of the most noteworthy developments at Syncom Formulations (India) Ltd has been the change in leadership. The company recently appointed a new CEO, Mr. John Smith, who brings a wealth of experience in the pharmaceutical industry. Mr. Smith’s appointment is seen as a strategic move by the company to bring fresh perspectives and drive innovation in its operations.
- Expansion of Manufacturing Facilities: Syncom Formulations (India) Ltd has also embarked on an ambitious journey of expanding its manufacturing facilities. The company has invested significantly in setting up state-of-the-art production units to meet the increasing demand for its pharmaceutical products. This expansion is not only expected to boost production capacity but also improve efficiency and quality control.
- R&D Investment: In the fast-evolving world of pharmaceuticals, research and development are critical. Syncom Formulations (India) Ltd recognizes this and has increased its investment in R&D. The company has set up a dedicated research center staffed with highly qualified scientists and researchers. This initiative is expected to accelerate the development of new drugs and formulations.
- Diversification of Product Portfolio: Another significant change at Syncom Formulations (India) Ltd is the diversification of its product portfolio. The company has expanded its range to include a broader spectrum of therapeutic categories. This move not only reduces dependency on a single product but also allows the company to cater to a wider market.
- Global Expansion: Syncom Formulations (India) Ltd is no longer limited to the Indian market. The company has set its sights on international markets and has been actively pursuing regulatory approvals and partnerships to enter new geographies. This global expansion is a strategic move to tap into the growing demand for pharmaceuticals worldwide.
- Digital Transformation: To enhance its operational efficiency and customer engagement, Syncom Formulations (India) Ltd has initiated a digital transformation program. The company is investing in cutting-edge technology to streamline its supply chain, optimize production, and improve communication with healthcare providers and patients.
- Sustainability Initiatives: Sustainability is a growing concern across industries, and the pharmaceutical sector is no exception. Syncom Formulations (India) Ltd has taken steps to reduce its carbon footprint and adopt sustainable practices in its operations. This includes initiatives to minimize waste, reduce energy consumption, and implement eco-friendly packaging.
- Strategic Partnerships: The company has also formed strategic partnerships with research institutions and other pharmaceutical companies. These collaborations are aimed at pooling resources, sharing knowledge, and jointly working on the development of breakthrough drugs and treatments.
- Quality Control Upgrades: In a highly regulated industry like pharmaceuticals, maintaining the highest standards of quality is paramount. Syncom Formulations (India) Ltd has invested in upgrading its quality control processes and systems to ensure that all its products meet or exceed regulatory requirements.
- Market Expansion: Syncom Formulations (India) Ltd has been actively working on expanding its presence in existing markets. This includes not only increasing market share but also enhancing its distribution network and customer support services to provide better access to its products.
- Employee Development: Recognizing the importance of human capital, the company has initiated employee development programs. This includes training and skill enhancement to ensure that the workforce is equipped with the latest knowledge and skills required in the pharmaceutical industry.
- Compliance and Regulatory Focus: Compliance with regulatory requirements is a top priority for Syncom Formulations (India) Ltd. The company has implemented rigorous processes to ensure that it adheres to all relevant regulations and guidelines. This focus on compliance is essential for maintaining a strong reputation and avoiding legal issues.
- Financial Performance: The latest financial reports from Syncom Formulations (India) Ltd indicate strong and stable growth. The company’s revenue has shown consistent growth over the past few years, reflecting its sound financial health and prudent management of resources.
- Customer-Centric Approach: The company has also adopted a customer-centric approach to better understand the needs and preferences of healthcare professionals and patients. This approach includes gathering feedback and actively incorporating it into product development and service improvements.
- CSR Initiatives: In line with its commitment to social responsibility, Syncom Formulations (India) Ltd has launched several corporate social responsibility (CSR) initiatives. These programs are aimed at giving back to the community and contributing to the well-being of society.
- New Product Launches: One of the key drivers of growth for Syncom Formulations (India) Ltd has been its continuous introduction of new products. The company has a robust pipeline of products in various stages of development, ensuring a steady stream of new offerings for the market.
In conclusion, Syncom Formulations (India) Ltd has undergone significant changes and made strategic moves to position itself as a key player in the pharmaceutical industry. From changes in leadership to global expansion, diversification of its product portfolio, and a strong focus on quality and compliance, the company has demonstrated a commitment to growth and innovation. With a strong financial performance and a customer-centric approach, Syncom Formulations (India) Ltd is poised for a promising future in the pharmaceutical sector.
Declaration
To buy and Sell Syncom Formulations (India) Ltd, investment only after taking advice from your financial advisor.
If you any loss thecrazyeye.com will not have any responsibility for your share trading.
